A brain injury doesn’t always end when the visible wound heals. For a lot of people—a car accident on I-65, a fall, a sports concussion, a blast exposure during military service—the harder chapter starts months later. The headaches linger. Concentration slips. And underneath it, a heavy, flat depression settles in, sometimes braided together with the hypervigilance and intrusive memories of PTSD. When that happens, the usual antidepressants often don’t do much.
That gap is why ketamine keeps coming up in conversations about brain injury. It works differently from the medications most people have already tried, and there’s a growing research effort aimed squarely at the mood and stress symptoms that follow a TBI. We want to walk through what’s actually known here, including the parts that are still unsettled, because this is a topic where overpromising would be a disservice.
Why Mood Suffers After a Brain Injury
Depression after a traumatic brain injury is not a sign of weakness or a simple emotional reaction to a rough stretch of life. It has a physical basis. The impact can disrupt the circuits that regulate mood, motivation, sleep, and emotional control, and it sets off an inflammatory response in the brain that can persist well beyond the initial injury.
The numbers bear this out. Depression is one of the most frequent complications after a TBI, and it shows up across the severity spectrum—not only after severe injuries but after concussions that never even required a hospital stay. Anxiety and PTSD frequently ride along with it, especially when the injury happened during a frightening event like combat, an assault, or a serious crash. So you often end up with a person facing depression, post-traumatic stress, cognitive fog, and chronic headache all at the same time.
Standard antidepressants were designed with the ordinary depressed brain in mind, and they weren’t built for this. They frequently underperform after a TBI, which leaves patients and clinicians looking for something that reaches the problem by another route.
Why Ketamine Enters the Picture
Most antidepressants act slowly on serotonin and related systems. Ketamine works on the glutamate system through the NMDA receptor and, downstream, appears to restore synaptic connections in a matter of hours to days rather than weeks. We describe this in more detail in our piece on how ketamine works, but the short version is that it targets the brain’s capacity to rebuild healthy connections—exactly the capacity that both depression and brain injury tend to erode.
Ketamine already has a strong evidence base in treatment-resistant depression and a growing one in PTSD. Since post-TBI mood problems are, almost by definition, treatment-resistant and often tangled with PTSD, it’s a logical candidate. The question researchers are now asking is whether the benefit that shows up in general treatment-resistant depression holds up specifically in people whose symptoms followed a brain injury.
What the Research Actually Shows
Here’s where careful language matters. There are two separate claims worth keeping apart.
The first claim—that ketamine can relieve depression and PTSD symptoms in people who happen to have a TBI history—rests on solid ground for the underlying conditions and a still-growing body of TBI-specific work. Clinical trials are currently underway testing subanesthetic ketamine for depression and post-traumatic stress in veterans with mild-to-moderate traumatic brain injury, with some primary results expected around late 2026. Other trials are comparing ketamine, stellate ganglion blocks, and combination approaches for TBI-associated headache and PTSD. The fact that the field is running these studies at all reflects genuine promise, but "underway" is not "finished." We’re honest with patients that the TBI-specific evidence is early.
The second claim is more speculative: that ketamine helps injured brain tissue itself recover. Laboratory and animal research has suggested ketamine may reduce neuroinflammation, quiet the microglial activation and inflammatory signals (like TNF and IL-6) that follow injury, and even suppress the destructive waves of electrical activity called spreading depolarization that can worsen damage after a TBI.
Ketamine has been postulated to play a role in neuroprotection due to its anti-inflammatory properties and its ability to decrease microglial activation, with a protective effect after traumatic brain injury likely tied to the suppression of spreading depolarization. — Summarized from preclinical TBI research, National Library of Medicine, PMC
That’s a genuinely interesting line of science, but it lives mostly in cell cultures and animal models right now. We do not present ketamine as a proven repair treatment for damaged brain tissue, and you should be wary of any clinic that does. What we can speak to responsibly is its role in the mood, anxiety, and post-traumatic symptoms that so often follow injury.
The Safety Question People Ask First
If you’ve read anything about ketamine and head injury, you may have run into an old caution: that ketamine raises intracranial pressure and should be avoided in brain injury. That warning came out of emergency and surgical settings involving acute, severe head trauma, where any change in pressure inside the skull is high-stakes.
Two things have changed the conversation. First, newer evidence has actually challenged that old contraindication, showing ketamine has favorable effects on breathing and cardiovascular stability that can make it attractive compared with some traditional sedatives in acute care. Second, and more relevant to our patients, outpatient ketamine for depression is a completely different situation from sedating someone in an ICU right after a crash. The people we see are typically well past the acute injury, living with lingering symptoms, and being treated with low, subanesthetic doses under continuous monitoring.
None of that means a TBI history is irrelevant. It’s exactly the kind of detail we review closely—alongside blood pressure, current medications, and any seizure history—when deciding whether ketamine is appropriate. You can read more about how we think about candidacy in is ketamine therapy safe and about the situations where we say no in when we decline ketamine for a patient.
Veterans, First Responders, and the Blast-Injury Overlap
This topic hits especially close to home for veterans and first responders. Blast exposure and repeated impacts can produce a brain injury history, and the same service that caused it often carries the trauma that drives PTSD. That overlap—TBI plus PTSD plus depression—is one of the more difficult problems in all of mental health care, and it’s precisely the population several current ketamine trials are built around.
We treat a number of veterans and first responders at our Franklin clinic, and we approach this group with particular care. Our related writing on ketamine for veterans and ketamine for first responders goes deeper into the trauma side of the equation. The point we’d make here is that a brain-injury history shouldn’t automatically close the door on a treatment that may help the depression and PTSD sitting on top of it.
How We’d Approach It
If you’re living with depression or PTSD that took hold after a brain injury, a thoughtful evaluation looks at the whole picture: when the injury happened, what symptoms have persisted, what you’ve already tried, your headache and seizure history, your medications, and your blood pressure. We’re also mindful that cognitive changes after a TBI can affect how someone experiences an infusion, so the calm, supported environment matters—which is part of why Marla stays present during infusions and why our therapy dogs, Walter White and Wilma, are part of the room.
The period after each session, the neuroplastic window, is worth taking seriously too. Rest, gentle routine, and supportive follow-up can help the mood gains take hold, which matters even more when the brain is already working to compensate for an old injury.
An Honest Bottom Line
Brain injury makes depression and PTSD harder to treat, and the standard tools frequently fall short. Ketamine offers a different mechanism, a real track record in the underlying conditions, and an active research effort aimed at the TBI population specifically. What we won’t do is oversell it. The TBI-specific trials are still in progress, the brain-repair claims remain largely preclinical, and every case deserves an individual look.
If you or someone you love is carrying the aftermath of a brain injury and the depression that came with it, we’d be glad to talk it through—honestly, without pressure, and with a clear line drawn between what the science has established and what it’s still figuring out.